InvestorsHub Logo
icon url

rafunrafun

03/12/21 12:17 PM

#329409 RE: luvbio #329404

Is JT missing an opportunity to do educate the public about Vascepa and its differences from Lovaza? Heck yes.

250,000 monthly Lovaza scripts. Do these people know what they're taking? Highly doubtful.

What have they done do educate the public? A few Vascepa commercials (that Brits laugh at).

How about differentiating Vascepa from Lovaza?
Besides the ABC Utah story, I haven't seen anything on TV / internet (excluding a few journals that no one reads).

JT had no problem appearing on CNBC in late 2019. Why the media blackout since then?

People didn't stop dying from CVD. More Americans have died from CVD than from COVID since COVID's inception.

And yes, JT has done a great job with other things, such as anything regulatory.

But promoting Vascepa?

I give him a big F for that.

Yes, the hand that was dealt to them (Du & COVID) was less than ideal, but their lack of doing anything promotion-wise to the public is inexcusable.

icon url

postes

03/12/21 12:32 PM

#329411 RE: luvbio #329404

In Denver...appointments are farther out, my Dr's offices are pretty full...I think we are about back to normal.